CARDIO-ONCOLOGY

Cardio-Oncology

Management of Toxicities in the Era of Immunotherapy

The development of immunotherapy in oncology field has revolutionized the prognosis of many types of cancer. 

Lire la suite keyboard_arrow_right

Pages 122
Taille 16 x 24
Type Relié
Langue Anglais
ISBN 9783030977436

Description détaillée : Cardio-Oncology

The immune checkpoint inhibitors target receptors whose inhibition increases the activity of immune system cells against tumor cells.

In recent years, new immunotherapies have been studied and approved in a growing number of tumors including melanoma, non-small cell lung cancer (NSCLC), and renal cell cancer (RCC).

 

  

What is the content of "Cardio-Oncology" ?

This volume provides a complete and updated state-of-art review regarding the management of cardiovascular toxicities from new immunotherapies.

The manuscript is divided into different sections starting from the relationship between cancer and immune system to let the reader understand the new molecular concepts under immunotherapy development. Subsequent chapters describe specifically the immunotherapy options in solid tumor treatment and the main features of the immuno-related cardiovascular complications.

This volume is written by experts in the oncological and cardiovascular fields and aims to provide to clinicians who approach current cancer patients a useful tool to move through the paths of modern cardio-oncology.

An important section would afford the most relevant interventions needed to manage the cardiac events, suggesting how to reduce their impact and effects on oncological outcomes.

The text concludes by addressing future perspectives in the cardio-immunology field, discussing many aspects such as the early detection of cardiovascular damage and the potential role of liquid biopsy in new damage-related biomarkers discovery.

Who are the authors of "Cardio-Oncology" ?

Antonio Russo, MD : Department of Oncology - A.O.U.P. "P. Giaccone" University Hospital. Palermo, Italy. 

Nicola Maurea, MD : Division of Cardiology, Istituto Nazionale Tumori⁻IRCCS-Fondazione G.Pascale, Napoli, Italy. 

Dimitrios Farmakis, MD, PhD, FESC, FHFA : Assoc. Professor, University of Cyprus Medical School,Shacolas Educational Centre for Clinical Medicine, Nicosia, Cyprus. Visiting Professor, National and Kapodistrian University of Athens Medical School, Athens University Hospital Attikon, Athens, Greece

Antonio Giordano, MD : Sbarro Institute for Cancer Research and Molecular Medicine and Center of Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA USA. 

Auteur(s): Cardio-Oncology

Antonio Giordano
139,00 €

Sur commande

Expédition sous 20 à 30 jours ouvrés

139,00 €

Bénéficiez de la remise de 5% en choisissant le retrait en magasin

 
Livraison à 0.01€ à partir de 35€

d'achats en France Métropolitaine

 
Satisfait ou remboursé

sous 14 jours ouvrés

 
Paiements sécurisés

 
Service client

Lundi au Vendredi : de 10h à 18h30
au 04 67 63 62 19 ou par email